Verona Pharma (VRNA)
NASDAQ: VRNA
· Real-Time Price · USD
105.26
-0.01 (-0.01%)
At close: Aug 15, 2025, 3:59 PM
105.27
0.01%
After-hours: Aug 15, 2025, 04:15 PM EDT
Verona Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -164.09M | -173.48M | -153.91M | -125.64M | -63.53M | -54.49M | -50.69M | -51.65M | -60.61M | -68.7M | -81.51M | -54.81M | -59.12M | -55.57M | -50.34M | -84.37M | -73.03M |
Depreciation & Amortization | 1.74M | 1.06M | 1.01M | 897.96K | 784.66K | 678.81K | 620K | 622K | 630K | 636K | 647K | 652K | 639K | 629K | 502K | 548.88K | 587.98K |
Stock-Based Compensation | 74.46M | 41.24M | 32.08M | 29.5M | 18.98M | 19.01M | 18.95M | 16.68M | 14.66M | 14.12M | 13.8M | 15.93M | 20.32M | 25.43M | 34.11M | 35.76M | 29.24M |
Other Working Capital | 10.93M | 17.53M | 6.37M | 29.26M | -9.78M | -13.35M | -6.33M | -11.63M | -7.79M | -3.59M | -16.96M | 11.94M | 17.83M | 3.58M | 199.64M | 183.78M | 183.82M |
Other Non-Cash Items | -941.27K | 36.8M | 33.3M | 19.67M | 6.6M | 1.62M | -3.19M | 664K | 2.81M | 4.82M | 7.32M | 3.47M | 1.36M | 239K | -674K | 254.63K | 487.34K |
Deferred Income Tax | n/a | n/a | -3.44M | -2.43M | -3.17M | -3.17M | 272K | -740K | n/a | n/a | -734K | -15.03M | -17.77M | -17.42M | -26.4M | -12.03M | -571.22K |
Change in Working Capital | -22.14M | -14.88M | 132.05K | 37.09M | -13.98M | -13.89M | -13.52M | -18.51M | -8.62M | -10.74M | -8.97M | 21.27M | 25.35M | 13.44M | 7.5M | -8.34M | -7.79M |
Operating Cash Flow | -119.81M | -122.21M | -103.8M | -53.87M | -58.42M | -50.24M | -47.56M | -52.93M | -51.13M | -59.86M | -69.45M | -28.53M | -29.21M | -33.25M | -35.3M | -68.18M | -51.08M |
Capital Expenditures | -519.01K | -535K | n/a | -45.01K | -15.99K | n/a | -280.39 | -157.72 | -28.98K | -28.98K | -29.7K | -40.82K | -12K | -12K | 229.39K | 73.55K | -0.19 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.84M | 8.97M | 9.79M |
Other Investing Acitivies | -580K | -61K | -61K | -16K | -16K | n/a | n/a | n/a | -176 | -176 | -12.18K | -12.18K | -12K | -12K | -9.05M | -9.04M | -8.98M |
Investing Cash Flow | -1.1M | -580K | -82.07K | -82.08K | -53.06K | -37.07K | -280.39 | -157.72 | -29.16K | -29.16K | -29.88K | -41K | -12K | -12K | 17K | 10.58K | 807.34K |
Debt Repayment | -29.76M | -29.76M | 92.77M | 92.77M | 22.52M | 32.52M | 10M | 10M | 10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 2.83M | n/a | -4M | -4M | -2.83M | n/a | -1.94M | -1.94M | -2.5M | -2.5M | -566.02K | -566.02K | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 195.93M | 179.35M | 87.86M | 98.68M | 2.17M | 7.12M | 4.57M | -5.59M | -6.36M | -8.98M | -12.49M | -4.55M | -7.64M | -6.85M | -2M | -53.98M | -50.36M |
Financial Cash Flow | 267.04M | 250.83M | 180.74M | 187.88M | 21.48M | 92.92M | 71.47M | 211.04M | 210.23M | 140.82M | 137.3M | -4.13M | -6.84M | -6.12M | -727K | 189.27M | 192.51M |
Net Cash Flow | 146.53M | 127.98M | 78.67M | 133.87M | -36.53M | 43.95M | 25.66M | 159.22M | 158.65M | 79.45M | 65.15M | -34.52M | -36.83M | -39.61M | -35.42M | 123.78M | 144.79M |
Free Cash Flow | -120.37M | -122.79M | -103.84M | -53.91M | -58.44M | -50.24M | -47.56M | -52.93M | -51.16M | -59.89M | -69.48M | -28.57M | -29.23M | -33.27M | -35.07M | -68.11M | -51.08M |